Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Relation between plasma and brain lipids

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Polygenic risk scores: how much do they add?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Impact of metabolic dysfunction on cognition in humans

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Remnant lipoproteins

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hypophosphataemia is common in patients with aneurysmal subarachnoid haemorrhage

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE OF REVIEW: This article evaluates recent experimental and human evidence regarding the involvement of lipids, lipoproteins, and apolipoproteins in neurodegenerative diseases, and reviews the current literature of the effects of cholesterol-lowering treatment on cognition.

RECENT FINDINGS: Plasma levels of traditional lipids and lipoproteins are not consistently associated with risk of dementia even though low plasma levels of apolipoprotein E, through unknown mechanisms, robustly predict future dementia. Experimental evidence suggests neuroprotective roles of several brain and cerebrospinal fluid apolipoproteins. Whether plasma levels of apolipoprotein E, or any other apolipoprotein with possible central nervous system and/or blood-brain barrier functions (apolipoproteins J, A-I, A-II, A-IV, D, C-I, and C-III) may become accessible biomarker components that improve risk prediction for dementia together with genetic risk variants and cardiovascular risk factors remains to be determined.

SUMMARY: Apolipoproteins with well established functions in peripheral lipid metabolism may play important roles for brain vascular health and Alzheimer's disease pathophysiology. Experimental work on lipids, lipoproteins, and apolipoproteins in the central nervous system together with robust prospective human studies will help to substantiate the drug target potential of these lipid components.

OriginalsprogEngelsk
TidsskriftCurrent Opinion in Lipidology
Vol/bind27
Udgave nummer3
Sider (fra-til)225-32
Antal sider8
ISSN0957-9672
DOI
StatusUdgivet - jun. 2016

ID: 49458767